BioScience Health Innovations Company Description
BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States.
It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system.
The company also provides services, including testosterone and hormonal Optimization, NAD+ and cellular health, and platform licensing and peptide delivery.
It sells its products through Amazon platform; and direct-to-consumer. The company was formerly known as Nowtransit Inc and changed its name to BioScience Health Innovations, Inc. in February 2025.
BioScience Health Innovations, Inc. is based in Bluffdale, Utah.
| Country | United States |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| CEO | Darren Lopez |
Contact Details
Address: 14857 South Concord Park Drive Bluffdale, Utah Utah United States | |
| Phone | 801 949 0791 |
Stock Details
| Ticker Symbol | BHIC |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Darren J. Lopez M.B.A. | Chairman of the Board, Chief Executive Officer and President |
| John Chymboryk | Chief Financial Officer and Director |
| Daniel Schmidt | Chief Technology Officer and Director |